Telemonitoring of Lung Function by Spirometry
Primary Purpose
Asthma in Children, Asthma
Status
Unknown status
Phase
Not Applicable
Locations
Hungary
Study Type
Interventional
Intervention
Inclouded telespirometry system
Sponsored by
About this trial
This is an interventional health services research trial for Asthma in Children focused on measuring Spirometry
Eligibility Criteria
Inclusion Criteria:
- Younger than 18 years
- signed ICF
- asthmatic children with 2-5 GINA score
- The children is open-minded for telespirometric measurements at home and is capable for those measurements
- Parent understands and supports the investigation
Exclusion Criteria:
- Withdrawal of consent
- Any disease which, by the investigators opinion, is a risk for the patients health and/or is contraindicating the participation in the study
- Bad general condition
Sites / Locations
- University of Szeged
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Telemedicine arm
Control arm
Arm Description
Outcomes
Primary Outcome Measures
Incidence of asthma exacerbations per year
Change of the incidence of asthma exacerbations per year using telespirometry system
Secondary Outcome Measures
expiratory Forced Vital Capacity (FVC), the maximum amount of air that can forcibly be blown out after full inspiration
Lung function parameters to predict asthma exacerbation
Forced Expiratory Volume in one second (FEV1), is the volume of air that can forcibly be blown out in first 1 second after full inspiration
Lung function parameters to predict asthma exacerbation
FEV1/FVC ratio (FEV1%)
Lung function parameters to predict asthma exacerbation
Peak Expiratory Flow (PEF), peak expiratory flow rate during expiration
Lung function parameters to predict asthma exacerbation
Forced Expiratory Flow at 25-75% of FVC (FEF25-75%), mean of forced expiratory flow over the middle half of the FVC
Lung function parameters to predict asthma exacerbation
The change of absenteeism days from work/school
Effect of the use of telemedicinal system for the asthma control
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT04447664
Brief Title
Telemonitoring of Lung Function by Spirometry
Official Title
Telespirometry: Home Monitoring of Asthmatic Patients With Spirometer
Study Type
Interventional
2. Study Status
Record Verification Date
March 2020
Overall Recruitment Status
Unknown status
Study Start Date
June 30, 2020 (Anticipated)
Primary Completion Date
May 31, 2021 (Anticipated)
Study Completion Date
July 31, 2021 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Szeged University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Asthma is the most common respiratory disorder in children that causes breathing problems. The patients may have respiratory symptoms such as cough, wheeze, or short of breath. Asthma can be mild or severe when daily activities become compromised. Generally, by application of proper treatment, asthma symptoms can be well controlled. However, the exacerbation of the disease often leads to acute respiratory adverse events that require hospitalization and school absenteeism.
In this study, we plan the remote monitoring of lung function parameters in asthmatic children (under 18 years of age). We hypothesize that the daily home monitoring of respiratory indices will predict the occurrence of exacerbation and the hospitalization can be lowered.
Asthmatic children arriving for the regular examinations to the Department of Pediatrics and Pediatric Health Care Center of the University of Szeged will be involved. The patients are randomly divided into two treatment groups, telemonitoring and control.
For both groups, general patient characteristics will be recorded, and lung function parameters will be measured with a clinical spirometer.
Patients in the telemedicine group receive the home mobile controlled spirometer and trained by a pediatric pulmonologist for home examination. The spirometers are handed for 12 months, and children are asked to perform measurements minimum 4 times per week (at least one day a week in the morning and in the evening). In the case of asthma attacks, more frequent measurements repeated several times a day are required. Children in the telemedicine group complete the Asthma Control Test (ACT) after each measurement, which provides a numerical score related to the severity of asthma symptoms. Lung function parameters measured by children and the ACT results are automatically uploaded to a clinical server where the pulmonologists and built-in algorithms are monitoring the quality of the data. In case of deterioration of the lung function parameters, the patients are called for a personal visit and their treatment can be revised.
Every three months, members of both groups come to the outpatient clinic for a personal visit, where the same examinations are performed.
Detailed Description
Asthma is the most common respiratory disorder in children characterized by periodic airway obstruction, bronchial hyper-responsiveness, and airway inflammation. The symptoms of asthma may include cough, wheeze, or bronchoconstriction with airflow limitation. The severity of asthma may vary from mild to severe. Mild asthma is associated with rear events of short of breath. However, the exacerbation of the disease often leads to acute respiratory adverse events with severe hypoxia that requires hospitalization. The hospital care involves travel costs for the children and parents, school and work absenteeism.
The primary objective of the study is to investigate whether the annual occurrence of asthma exacerbation can be decreased by the use of the telespirometry system. Another objective is to determine which lung function parameters are best to predict asthma exacerbation.
To address these aims we plan to involve two groups (telemonitoring and control) of asthmatic children with GINA 2-5 stage under 18 years of age. Poor general condition, any disease which endangers the health of the volunteer or contraindicates the study and lack of parental consent are defined as the exclusion criteria.
The lung function in the children in both groups will be monitored by conventional spirometric assessment performed at the Department of Pediatrics and Pediatric Health Care Center of the University of Szeged. After each lung function assessments children will be asked to fill the Asthma Control Test (ACT).
Patients in the telemedicine group receive the home mobile controlled spirometer and trained by a pediatric pulmonologist for home examination. The spirometers are handed for 12 months, and children are asked to perform measurements minimum 4 times per week (at least one day a week in the morning and in the evening). In the case of asthma exacerbation, more frequent measurements repeated several times a day are required. Children in the telemedicine group complete the ACT after each measurement, which provides a numerical score related to the severity of asthma symptoms. Lung function parameters measured by children and the ACT test results are automatically uploaded to a clinical server where the pulmonologists and built-in algorithms are monitoring the quality of the data. In case of deterioration of the lung function parameters, the patients are called for a personal visit and their treatment can be revised.
Every three months, members of both groups come to the outpatient clinic for a personal visit, where the same examinations are performed.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Asthma in Children, Asthma
Keywords
Spirometry
7. Study Design
Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
52 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Telemedicine arm
Arm Type
Experimental
Arm Title
Control arm
Arm Type
No Intervention
Intervention Type
Device
Intervention Name(s)
Inclouded telespirometry system
Intervention Description
Components of the system: Portable digital ultrasonic spirometer (Uscom SpiroSonic MOBILE), android mobile application, clinical web cloud application
Primary Outcome Measure Information:
Title
Incidence of asthma exacerbations per year
Description
Change of the incidence of asthma exacerbations per year using telespirometry system
Time Frame
12 months
Secondary Outcome Measure Information:
Title
expiratory Forced Vital Capacity (FVC), the maximum amount of air that can forcibly be blown out after full inspiration
Description
Lung function parameters to predict asthma exacerbation
Time Frame
12 months
Title
Forced Expiratory Volume in one second (FEV1), is the volume of air that can forcibly be blown out in first 1 second after full inspiration
Description
Lung function parameters to predict asthma exacerbation
Time Frame
12 months
Title
FEV1/FVC ratio (FEV1%)
Description
Lung function parameters to predict asthma exacerbation
Time Frame
12 months
Title
Peak Expiratory Flow (PEF), peak expiratory flow rate during expiration
Description
Lung function parameters to predict asthma exacerbation
Time Frame
12 months
Title
Forced Expiratory Flow at 25-75% of FVC (FEF25-75%), mean of forced expiratory flow over the middle half of the FVC
Description
Lung function parameters to predict asthma exacerbation
Time Frame
12 months
Title
The change of absenteeism days from work/school
Description
Effect of the use of telemedicinal system for the asthma control
Time Frame
12 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
6 Years
Maximum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Younger than 18 years
signed ICF
asthmatic children with 2-5 GINA score
The children is open-minded for telespirometric measurements at home and is capable for those measurements
Parent understands and supports the investigation
Exclusion Criteria:
Withdrawal of consent
Any disease which, by the investigators opinion, is a risk for the patients health and/or is contraindicating the participation in the study
Bad general condition
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Katalin Kapus, MD
Phone
+3662545331
Email
kapus.katalin@med.u-szeged.hu
Facility Information:
Facility Name
University of Szeged
City
Szeged
ZIP/Postal Code
6720
Country
Hungary
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Balázs Bende, Md
Phone
+36-62-546-895
Email
bende.balazs@med.u-szeged.hu
First Name & Middle Initial & Last Name & Degree
Zoltán Novák, Prof. MD
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Telemonitoring of Lung Function by Spirometry
We'll reach out to this number within 24 hrs